Jazz Pharmaceuticals plc (JAZZ) revenue & profit
Jazz Pharmaceuticals plc (JAZZ): revenue $4.3B, net income -$356.1M in 2025; latest quarter +15.5% year over year. From SEC filings.
$4.3BRevenue 2025
TickerJAZZ (Nasdaq)
IndustryHealthcare · Pharmaceutical Preparations
Revenue 2025$4.3B
Net income 2025-$356.1M
Net margin-8.3%
Annual revenue growth+4.9%
Latest quarter (2026 Q2) · Revenue$1.2B
vs. same quarter last year+15.5%
Latest quarter · Net income$192.8M
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $3.7B | -$224.1M | |
| 2023 | $3.8B | $414.8M | |
| 2024 | $4.1B | $560.1M | |
| 2025 | $4.3B | -$356.1M |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.